Richard Beals
Psychiatric/Mental Health · Mesa, AZNPI 1669884847
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 584 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 584 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$964
- Tris Pharma Inc$921
- Corium, LLC$821
- Ironshore Pharmaceuticals Inc.$787
- Axsome Therapeutics, Inc.$700
- plus $5K from 25 others
What the payments were for
- Food & beverage$10,227100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 110 | $1,532 |
| Otsuka America Pharmaceutical, Inc. | 62 | $964 |
| Tris Pharma Inc | 65 | $921 |
| Corium, LLC | 45 | $821 |
| Ironshore Pharmaceuticals Inc. | 43 | $787 |
| Axsome Therapeutics, Inc. | 30 | $700 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $673 |
| Sunovion Pharmaceuticals Inc. | 29 | $585 |
| Lundbeck LLC | 28 | $529 |
| Supernus Pharmaceuticals, Inc. | 18 | $403 |
| Alkermes, Inc. | 14 | $312 |
| Vanda Pharmaceuticals Inc. | 16 | $302 |
| Johnson & Johnson | 12 | $255 |
| Bausch Health US, LLC | 12 | $234 |
| Merck | 10 | $194 |
| Collegium Pharmaceutical, Inc. | 8 | $150 |
| Almatica Pharma LLC | 4 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $124 |
| Vertical Pharmaceuticals, LLC | 5 | $105 |
| Idorsia Pharmaceuticals US Inc | 5 | $82 |
| Jazz Pharmaceuticals Inc. | 4 | $81 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| Eisai Inc. | 4 | $61 |
| Neos Therapeutics, LP | 4 | $61 |
| Alfasigma USA, Inc. | 3 | $40 |
| Biogen | 1 | $29 |
| Noven Therapeutics, LLC | 1 | $16 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
| Avion Pharmaceuticals | 1 | $16 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$122
How this compares
$10,231 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyvanseLisdexamfetamine Dimesylate | 22 | $8,058 |
| Chlorpromazine Hcl | 12 | $2,157 |
| Risperidone | 15 | $1,005 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $124 | $8,05822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Other psychiatric/mental health in Mesa
- Stacy UnderwoodMesa$252K
- Jesika McKenzieMesa$36K
- Gail ZivMesa$29K
- Rebecca DepalmaMesa$19K
- Troy FultonMesa$9K
- Joan ButlerMesa$8K
- Julie AngileriMesa$6K
- Ana WilliamsMesa$6K
- Elizabeth ElliottPhoenix$363K
- Diane StrickerGilbert$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.